Precision instruments and services company, Mettler-Toledo International Inc. (NYSE:MTD), has seen a number of insider selling activities in the recent months. Last week, Director Wah-Hui Chu completed two separate transactions related to stock sales: one on March 2nd, where he sold 300 shares worth $435,000; and another on February 28th, where he sold an additional 3,556 shares for a total value of just under $5.1 million. Similarly, Director Olivier A. Filliol sold 10,000 MTD shares at market-average price of $1,433.61 per share on February 28th. These sales have raised concerns amongst investors about the financial stability of the firm.
Despite these insider activities however, the company’s business operations remain stable as it continues to provide precision instruments and services for a variety of applications in industries such as laboratory research, industrial production and food retailing among others. Mettler-Toledo International remains committed to scientific innovation and discovery by providing automated solutions for drug development and metal detection systems used in production packaging.
One institutional investor seems less convinced about the long-term viability of the company’s share price however – Central Trust Co cut its stake in Mettler-Toledo International by almost 17% in Q4 2018 according to their most recent regulatory filing with the Securities and Exchange Commission (SEC). Their decision was based on professional analysis that suggested they no longer saw MTD as a viable investment opportunity due to recent insider sales.
The string of insider trading activity has certainly caught investors’ attention in terms of MTD’s financial performance outlook. However not all is doom and gloom with Mettler-Toledo still froming part of integral solutions utilized by various application areas worldwide. At this point it remains unclear whether further regulatory scrutiny or action will take place due to these trades or if Centrak Trust will resume buying shares of MTD in the future. Current indicators suggest investors should proceed with caution when it comes to investing in Mettler-Toledo International, Inc.
Mettler-Toledo International Inc.: An Upward Trajectory in Multiple Industries
Mettler-Toledo International Inc.: A Company on the Rise
Mettler-Toledo International Inc. (NYSE:MTD) has caught the attention of institutional investors and hedge funds, with many making significant changes to their positions in the company. CVA Family Office LLC acquired an additional 8 shares, while Allworth Financial LP added 7 more to its stake, increasing its position by 43.8% during Q4 of 2020. Guardian Wealth Advisors LLC recently acquired a new position worth $35,000 in the third quarter. EverSource Wealth Advisors LLC raised its position by a staggering 250%, with Standard Family Office LLC also acquiring a new stake in Mettler-Toledo International’s stock.
This unprecedented interest can be attributed to the fact that Mettler-Toledo International provides precision instruments and services for customers in various industries such as laboratory, industrial production, logistics, food retailing, drug discovery and development as well as metal detection and other end-of-line inspection systems used in production and packaging.
Based on data from Bloomberg.com, eight research analysts have rated the company, with five rating it hold and three calling it a buy. The consensus price target of $1,450.71 indicates bullishness among market experts with JPMorgan Chase & Co rating Mettler-Toledo International from an “underweight” to a “neutral” rating and providing them with a higher price objective of $1,350.00.
At time of writing (April 2021), NYSE:MTD is currently trading at US$1500.92 per share – within its 52-week high range. With a market capitalization of US$33.13 billion, PEG ratio of 2.46, beta of 1.17 calculated over one year provide solid investment fundamentals for those looking for mid-to-long-term growth – especially considering Mettler Toledo’s last four-quarter earnings per share (EPS) which took the traders by surprise.
On February 10th, 2021 Mettler-Toledo International had a reported record-breaking revenue of US$1.06 billion dollars, exceeding analysts’ estimates of $1.03 billion. The company’s EPS was $12.10, resulting in a net margin of 22.26%, which impressed key industry figures and shareholders alike.
Therefore, it is safe to say that Mettler-Toledo International continues on an upward trajectory as it provides analytical instruments with automated solutions that cater not just to the healthcare industry but across multiple sectors such as manufacturing, food production, and logistics industries. With statistics indicating potential growth factors such as its return on equity ratio and bullish outlook from investors and trades alike; Mettler Toledo appears as a financially stable investment opportunity with huge growth prospects for those looking to invest in long-term growth stocks within diverse industries.
Source: beststocks.com
